- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04333264
Clinical Analysis of Suction Drainage in Cementless Hip Replacement
April 1, 2020 updated by: Bartosz Paweł
Clinical Analysis of Suction Drainage in Cementless Hip Replacement - a Prospective Randomized Study
Randomized prospective study assessing suction drainage in total hip arthroplasty.
Group without drainage, 50 hips, compared with group with suction drainage, 50 hips.
Both groups will be asses clinically (ROM scale, VAS), laboratory and radiology (USG).
In the actually literature there are no benefits using closed suction drainage after primary total hip arthroplasty.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age between 30-80
- primary hip osteoarthritis
Exclusion Criteria:
- secondary hip osteoarthritis
- autoimmune disease
- congenital or secondary coagulopathy
- vein or artery thrombosis
- renal or liver failure
- cemented or hybrid alloplasty,
- no consent from the patient
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: suction drainage
Patients will be dived with randomization in to two groups: with and without closed suction drainage after primary total hip arthroplasty
|
After primary total hip arthroplasty closed suction drainage will be used.
|
Active Comparator: no suction drainage
Patients will be dived with randomization in to two groups: with and without closed suction drainage after primary total hip arthroplasty
|
After primary total hip arthroplasty closed suction drainage won't be used.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hip hematoma size in USG
Time Frame: 3 days after surgery
|
Size in millimeters fluid collection in supine position above femoral neck.
|
3 days after surgery
|
Hemoglobin levels
Time Frame: 3 days after surgery
|
Hb levels after surgery, difference between two groups
|
3 days after surgery
|
C-reactive protein levels
Time Frame: 3 days after surgery
|
C-reactive protein levels after surgery, difference between two groups
|
3 days after surgery
|
Visual Analog Scale punctation
Time Frame: 3 day after surgery
|
Pain level after surgery in Visual Analog Scale scale 0-10 pts.
where 0-no pain, 10-most painful.
|
3 day after surgery
|
Hip range of movement
Time Frame: 3 days after surgery
|
Differences between hip ROM after surgery
|
3 days after surgery
|
Wound exudation
Time Frame: 3 days after surgery
|
Assessing wound dehiscence after surgery, 1-exudation appear, 0-dry dressing
|
3 days after surgery
|
Soft tissue hematoma
Time Frame: 3 days after surgery
|
USG hematoma appearance in soft tissue around the hip
|
3 days after surgery
|
Intraoperative bleeding
Time Frame: 1 day
|
All amount of blood loss intraoperative with hidden bleeding, with use of Gross formula.
|
1 day
|
Blood transfusion
Time Frame: 14 days after surgery
|
Need of blood transfusion after operation
|
14 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Infection
Time Frame: 30 days after surgery
|
Superficial or deep infection after surgery
|
30 days after surgery
|
Deep vein thrombosis
Time Frame: 30 days after surgery
|
Occurrence lower limb thrombosis after surgery
|
30 days after surgery
|
Readmission
Time Frame: 30 days after surgery
|
Need to readmission after surgery
|
30 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Pawel Bartosz, Prof. A. Gruca Teaching Hospital in Otwock
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2016
Primary Completion (Actual)
January 1, 2020
Study Completion (Actual)
February 1, 2020
Study Registration Dates
First Submitted
March 30, 2020
First Submitted That Met QC Criteria
April 1, 2020
First Posted (Actual)
April 3, 2020
Study Record Updates
Last Update Posted (Actual)
April 3, 2020
Last Update Submitted That Met QC Criteria
April 1, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1/032016
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arthropathy of Hip
-
Ospedale Edoardo BassiniCompletedRegional Anesthesia Morbidity | Arthropathy of Hip | Hip ArthropathyItaly
-
Super Inspired LLCRecruitingArthropathy of Knee | Arthropathy of HipUnited States
-
Medical University of South CarolinaCompletedArthropathy of Knee | Arthropathy of HipUnited States
-
Hvidovre University HospitalCompletedArthropathy of Knee | Arthropathy of HipDenmark
-
Diskapi Teaching and Research HospitalCompletedArthropathy of Knee | Arthropathy of HipTurkey
-
Universidad de ZaragozaCompletedArthropathy of Knee | Arthropathy of HipSpain
-
Centre Hospitalier Universitaire de la RéunionCompletedArthropathy of Knee | Arthropathy of HipRéunion
-
University of PennsylvaniaSuspendedArthropathy of Knee Joint | Arthropathy of Hip JointUnited States
-
Ohio State UniversityTerminatedArthropathy of Knee | Opioid Use | Arthropathy of HipUnited States
-
Gruppo Bioimpianti S.r.l.RecruitingArthropathy of HipFrance
Clinical Trials on suction drainage
-
Nova Scotia Health AuthorityCompletedPneumothorax | AtelectasisCanada
-
The University of Hong KongThe University of Hong Kong-Shenzhen HospitalUnknown
-
University of Sao PauloCompleted
-
Fundació Institut de Recerca de l'Hospital de la...Instituto de Salud Carlos IIICompletedTotal Knee ArthroplastySpain
-
Yale UniversityMedela AGCompleted
-
Beijing Friendship HospitalRecruitingAll Diseases That Require Gastrointestinal Open SurgeryChina
-
Medical University of WarsawCentre of Postgraduate Medical EducationNot yet recruitingTotal Knee Replacement
-
Seoul National University HospitalCompletedPancreatic FistulaKorea, Republic of
-
Universidade Federal de GoiasAraujo Jorge HospitalCompletedBreast Cancer | Complications | SeromaBrazil